Bill Baumel

Bill Baumel is currently a Board of Directors at Clarametyx Biosciences, Inc. Prior to that, they were with ScriptDrop, DAtAnchor Inc., Alviere, eFuse, Aware, Genetesis, Immuta, Ohio Innovation Fund, and Stirling Ultracold, Division of Global Cooling, Inc. Bill has over 20 years of experience in startups and venture capital.

Bill Baumel has an MBA from the University of Michigan - Stephen M. Ross School of Business with a focus in finance, strategy, and marketing. Bill also has a BS from The Ohio State University in Honors Accounting & Economics. Bill is also a Certified Public Accountant.